Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Behavioral: physical therapist instruction and monitoring via teleconferencing	-	-	-	-	[1] 46 💬
2	Device: activity monitor	Methamidophos	-	-	-	[1] 113 💬
3	Device: continuous glucose monitor	Dextrose, unspecified form	-	-	-	[1] 65 💬
4	Device: continuous glucose monitor (cgm)	Dextrose, unspecified form	-	-	-	[1] 299 💬
5	Device: continuous glucose monitoring	Dextrose, unspecified form	-	-	-	[2] 75, 299 💬
6	Device: flash glucose monitoring system	Dextrose, unspecified form	-	-	-	[1] 49 💬
7	Device: insertable cardiac monitor	Methamidophos	-	-	-	[1] 58 💬
8	Device: mayo interactive breath hold monitor	Methamidophos	-	-	-	[2] 298, 300 💬
9	Device: medication event monitoring system (mems)	-	-	-	-	[1] 13 💬
10	Device: niox mino® airway inflammation monitor	Methamidophos	-	-	-	[1] 98 💬
11	Device: omnidirectional accelerometer monitor (3x3 cm and 16 g, actical®, philips respironics)	Methamidophos	-	-	-	[1] 118 💬
12	Device: philips intelivue mp70 monitor	Methamidophos	-	-	-	[1] 70 💬
13	Device: use of bioanalytical assay to monitor plasma levels of perhexiline	Methamidophos	[2] D05442, D08340 💬	[8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬	[45] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 58 💬
14	Device: wristband physical activity monitor	Methamidophos	-	-	-	[1] 13 💬
15	Diagnostic test: continuous glucose monitoring	Dextrose, unspecified form	-	-	-	[1] 299 💬
16	Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels	Chromium	-	-	-	[1] 46 💬
17	Monitor	Methamidophos	-	-	-	[18]  2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
18	Other: cough monitor	Methamidophos	-	-	-	[1] 85 💬
19	Other: e-monitoring	-	-	-	-	[1] 97 💬
20	Other: fitbit activity monitor	Methamidophos	-	-	-	[1] 49 💬
21	Other: noninvasive actigraphy monitor	Methamidophos	-	-	-	[1] 86 💬
22	Procedure: 2-hour holter monitor	Methamidophos	-	-	-	[1] 19 💬
23	Procedure: cardiac monitoring	-	-	-	-	[1]  6  💬
24	Procedure: continuous glucose monitoring system (cgms)	Dextrose, unspecified form	-	-	-	[1] 299 💬

Back to top